Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alan Fournier’s Pennant Capital Picked $HII

Alan Fournier’s Pennant Capital disclosed its brand-new position in Huntington Ingalls Industries, Inc. (HII) on November 28th. According to the filing, Pennant Capital now takes 2.73 million shares in HII, corresponding to a 5.6% passive stake ownership. Pennant Capital did not have share in HII before. It’s possible that the firm began to purchase in early October at about $25 per share. Huntington Ingalls Industries was a prior subsidiary of Northrop Grumman Corporation (NOC), and it was spun off from Northrop Grumman on March 31st, 2011. Now HII is trading at $31, losing 18% after March.


Pennant Capital Management is a financial investment firm based out of an office on Main Street in Chatham. The firm primarily focuses on individual clients, but Pennant also handles corporate accounts. The firm reported $4.07 million in its third quarter 13F filing. It mainly invests in Healthcare, Services, Industrial Goods, Consumer Goods, Financial, and Basic Materials sector.

Huntington Ingalls Industries, Inc. provides nuclear and non-nuclear ships for the U.S. Navy and Coast Guard. The company specializes in nuclear-powered aircraft carriers, aircraft carriers, warships, and nuclear-powered submarines. The company operates three divisions: Ingalls Shipbuilding and Newport News Shipbuilding. The company was founded in 1886 and is based in Newport News, Virginia.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!